Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.5.0.2
Accrued expenses and other current liabilities
 6 Months Ended
Jun. 30, 2016
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

 

Note 7 — Accrued expenses and other current liabilities

 

Accrued expenses and other current liabilities consisted of the following (in thousands):

 

 

 

June 30,
2016

 

December 31,
2015

 

 

 

 

 

 

 

Accrued purchases and clinical trial expenditure

 

$
7,049 

 

$
6,406 

 

Accrued employee compensation and benefits payable

 
545 

 
368 

 

Other current liabilities

 
129 

 
744 

 

 

 

 

 

 

 

 

 

$
7,723 

 

$
7,518